1-3 of 3
Triantafyllia Karakousi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2174: Sirpiglenastat (DRP-104), a novel broad acting glutamine antagonist, has therapeutic potential in targeting KEAP1-mutant lung cancer

Sarah LeBoeuf, Ray Pillai, Shih Ming Huang, Triantafyllia Karakousi, Warren Wu, Volkan Sayin, Robert Wild, Thales Papagiannakopoulos
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2174.
DOI: https://doi.org/10.1158/1538-7445.AM2022-2174
Published: 15 June 2022
View article
Journal Articles

Abstract 420: Rlf-Mycl1 gene fusion as a novel oncogenic driver in a mouse model of small cell lung cancer

Metamia Ciampricotti, Triantafyllia Karakousi, Alvaro Quintanal Villalonga, Viola Allaj, Andrea Ventura, Triparna Sen, JT Poirier, Thales Papagiannakopoulos, Charles M. Rudin
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 420.
DOI: https://doi.org/10.1158/1538-7445.AM2020-420
Published: 15 August 2020
View article
Journal Articles

Abstract 2569: Uncovering metabolic bottlenecks in KEAP1 mutant lung cancer

Sarah E. LeBoeuf, Warren Wu, Triantafyllia Karakousi, Robert Wild, Thales Papagiannakopoulos
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2569.
DOI: https://doi.org/10.1158/1538-7445.AM2020-2569
Published: 15 August 2020
View article